Publication
Abstract
Realization of part of clinical trial called: Randomized, multicenter, open Phase III Bruton tyrosine kinase inhibitor PCI-32765 vs. chlorambucil for 65-year-olds and older patients with previously untreated chronic lymphocytic leukemia or lymphoma, small cell